Virobay
2013 – Virobay and LEO Pharma initiate a Phase 1 Trial of VBY-891, a compound intended for oral treatment of psoriasis more
2012 – Virobay's Cathepsin S selected as one of the Top 10 Anti-Inflammatory/Autoimmune Projects to Watch more
2012 – LEO Pharma A/S has entered into a multi-million dollar collaboration with Virobay Inc. to develop an oral treatment for psoriasis more
2010 – Virobay closes Series B financing
2008 – Virobay assets solve the chemical challenge of cathepsin inhibitor design; multiple development candidates are poised for Phase I
2007 – In-licensed cathepsin protease inhibitor assets
2007 – Filed IND and initiated Phase I trial with lead protease inhibitor as an oral treatment for Hepatitis C
2006 – Founded as a protease inhibitor drug discovery and development company
Contact Us
Virobay Inc.
1490 O’Brien Drive, Suite G
Menlo Park, CA 94025
Tel: +1 650-833-5700
Fax: +1 650-833-6892
Email: info@virobayinc.com
Directions to Virobay
From San Francisco airport
Take 101 South (17 miles)
Exit on Willow Road East (~0.6 miles)
Turn right into O’Brien Drive (0.6 miles)
1490 is the second to last building on the right;
we are in Suite G access through the center door
From San Jose airport
Take 101 north (15 miles)
Exit on Willow Road East (~0.6 miles)
Turn right into O’Brien Drive (0.6 miles)
1490 is the second to last building on the right;
we are in Suite G access through the center door
